CDC20 has been reported to be significantly elevated in tumor tissues with poor differentiation and has been linked to poor prognosis in pancreatic cancer [33], lung cancer [34], bladder cancer [35], colon cancer [36], oral squamous cell carcinomas [37], and breast cancer [38]. Here, CDC20 is linked to lung carcinoma.